Results 111 to 120 of about 1,240 (178)

Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma. [PDF]

Front Immunol
Karapetyan L, Kuriakose J, Perez MC, Ali JR, Hall MS, Beatty MS, Otteni CD, Xu J, Kalos D, Moran-Segura C, Vieira E, Adams K, Rodriguez-Alfonso L, DiMaggio EC, Bailey H, Pinilla-Ibarz J, Locke FL, Mullinax JE, Chen PL, Song J, Messina JL, Johnson DB, Morgan DS, Eroglu Z, Khushalani NI, Sondak VK, Sarnaik AA, Tsai K, Mulé JJ, Pilon-Thomas S.   +29 more
europepmc   +1 more source

Antiochos Soter and the Third Syrian War [PDF]

, 2018
Erickson, Kyle
core  

Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator. [PDF]

J Clin Oncol
Varey AHR, Li I, El Sharouni MA, Simon J, Dedeilia A, Ch'ng S, Saw RPM, Spillane AJ, Shannon KF, Pennington TE, Rtshiladze M, Stretch JR, Nieweg OE, van Akkooi A, Sullivan RJ, Boland GM, Gershenwald JE, van Diest PJ, Scolyer RA, Long GV, Thompson JF, Lo SN.   +21 more
europepmc   +1 more source

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting. [PDF]

Clin Cancer Res
Ventin M, Cattaneo G, Arya S, Jia J, Gelmi MC, Sun Y, Maggs L, Ksander BR, Verdijk RM, Boland GM, Jenkins RW, Haq R, Jager MJ, Wang X, Ryeom S, Ferrone CR.   +15 more
europepmc   +1 more source

Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failure. [PDF]

ESMO Open
da Silva IP, Zimmer L, Blay JY, Maio M, Larkin J, Grimm MO, Puri S, Butler MO, Patel S, Thakkar PK, Long GV, Melero I.   +11 more
europepmc   +1 more source

Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma. [PDF]

Clin Cancer Res
Tarhini AA, Obermayer A, Lee SJ, LaFramboise WA, Hodi FS, Karunamurthy AD, Eljilany I, Chen DT, Hwu P, El Naqa IM, Streicher H, Sondak VK, Storkus WJ, Butterfield LH, Shaw TI, Kirkwood JM.   +15 more
europepmc   +1 more source

A Comparative Study of the Antioxidant Status and Biotechnological Potential of <i>Bracteacoccus minor</i> (Chlorophyceae) Strains. [PDF]

Int J Mol Sci
Maltseva I, Kochubey A, Yakoviichuk A, Maltseva S, Kulikovskiy M, Maltsev Y.   +5 more
europepmc   +1 more source

Hydraulic loading, nutrients and phytoplankton in the Hirsel Loch (Berwickshire) - a review of work done and recommendations for future studies in the light of a proposed lowering of the water level [PDF]

, 1994
Bailey-Watts, A.E., Gunn, I.D.M., Kirika, A., Lyle, A.A., Wiltshire, N.J.   +4 more
core  

Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients. [PDF]

Clin Cancer Res
Sato T, Butler MO, Piperno-Neumann S, Hassel JC, Nathan P, Shoushtari AN, Rutkowski P, Carvajal RD, Baurain JF, Schlaak M, Piulats JM, Sullivan RJ, Ochsenreither S, Dummer R, Kirkwood JM, Ikeguchi A, Joshua AM, Middleton MR, Edukulla R, Pfeiffer C, Sacco JJ.   +20 more
europepmc   +1 more source

Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment. [PDF]

Genome Biol
Soupir AC, Hayes MT, Peak TC, Ospina O, Chakiryan NH, Berglund AE, Stewart PA, Nguyen J, Segura CM, Francis NL, Echevarria PMR, Chahoud J, Li R, Tsai KY, Balasi JA, Peres YC, Dhillon J, Martinez LA, Gloria WE, Schurman N, Kim S, Gregory M, Mulé J, Fridley BL, Manley BJ.   +24 more
europepmc   +1 more source